you are here: HomeNewsIndia

Coronavirus update: India records highest single-day rise so far with over 1.68 lakh new cases

The active cases have surpassed the 12-lakh mark, while the death toll increased to 1,70,179with 904 daily new fatalities, the highest since October 18, the data updated at 8 am showed.

April 12, 2021 / 10:46 AM IST
Coronavirus

Coronavirus

India hit a new coronavirus infection record with 1,68,912new cases, the highest single-day rise so far, taking the total tally of cases to 1,35,27,717, according to the Union Health Ministry data updated on Sunday. The national COVID-19 recovery rate has fallen below 90 per cent.

The active cases have surpassed the 12-lakh mark, while the death toll increased to 1,70,179 with 904 daily new fatalities, the highest since October 18, the data updated at 8 am showed.

Registering a steady increase for the 33rd day in row, the active cases have increased to 12,01,009 comprising 8.88 per cent of the total infections, while the recovery rate has further dropped to 89.86 per cent.

The active caseload was at its lowest at 1, 35,926 on February 12 and it was at its highest at 10,17,754 on September 18, 2020.

The number of people who have recuperated from the disease surged to 1,21,56,529, while the case fatality rate has further dropped to 1.26 per cent, the data stated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

According to the ICMR, 25,78,06,986 samples have been tested up to April 11 with 11,80,136 samples being tested on Sunday.
PTI
first published: Apr 12, 2021 10:33 am

stay updated

Get Daily News on your Browser
Sections